Synthesis of a series of new substituted benzimidazole derivatives by the condensation of o-phenylenediamine with urea to give 1,3-dihydro-benzimidazol-2-one which reacted with phosphoryl chloride to give 2-chloro-1H-benzimidazole is reported. The product was then alkylated at the benzimidazole NH with different electrophilic reagents leading to functionalized derivatives. Structures of the newly synthesized products have been deduced on the basis of spectral and analytical data. The synthesized compounds were screened for their antimicrobial activity. This exhibited some promising results towards testing organism in-vitro.
Introduction
Benzimidazoles and their analogs are well known biologically active N-containing heterocycles [1] , widely used as drugs such as proton pump inhibitor omeprazole [2, 3] , antihelmentic albendazole [4, 5] , anti-dopaminergic domperidone [6, 7] , anti-psychotic pimozide [8, 9] , etc. Some of their analogs are the constitutional parts of the marine alkaloids, such as kealiiquinone and antitumor agents such as pyrrolo [1,2-a] benzimidazole quninone (APBI-A) [10, 11] . Specifically, the 2-substituted analogues of benzimidazoles are known to be potent biologically active compounds [12] [13] [14] . Some of the important benzimidazole derivatives have been reported as thyroid receptor agonists [15] , gonadotropin releasing hormone receptor antagonists [16] , non-nucleoside HIV-1 reverse transcriptase inhibitors [17] and interestingly alkynyl benzimidazoles as modulators of metabotropic glutamate receptors [18] etc. We have also published some series of biologically active benzimidazoles [19] [20] [21] . Owing to the immense biological importance of benzimidazole derivatives, we now synthesized some novel class of benzimidazole derivatives and their biological activity screening studies.
Experimental

Chemicals
o-Phenylenediamine acid, urea, phosphoryl chloride obtained from Aldrich. Hydrochloric acid, sodium hydroxide, potassium carbonate, alkylating agent and solvents used were of commercial grade only.
Instrumentations
Melting points recorded on a MRVIS Series, Lab. India Instrument. TLC analysis was done using pre-coated silica gel plates and visualization was done using iodine/UV lamp. Infrared spectra were recorded on Perkin Elmer model FT-IR using the KBr disc. 1 H NMR spectra of the compounds were recorded on BRUKER Avance II 400 MHz NMR spectrometer with CDCl3 as solvent unless otherwise mentioned. Elemental analysis was carried out on a Perkin Elmer Series II Elemental Analyzer 2400. 
Synthesis
Synthesis of 1,3-dihydro-benzimidazol-2-one (2)
To a solution of o-phenylene diamine (1) (5 g, 0.046 mol) in DMF was added urea (5.52 g, 0.092 mol) and mixture heated to 135-140 °C for 12 h. When the reaction was complete, DMF was removed in vacuum; separated solid was washed with water and then dissolved in aq. 10% NaOH solution. The aqueous alkaline solution was filtered and neutralised with aq. HCl (35%). The separated product was filtered, washed and dried to obtain pure compound 2 (1,3-dihydro-benzimidazol-2-one) (Scheme 1). Yield: 5.8 g, 94%. M.p.: 99-101 °C (Lit. [22] : 100-102 °C).
Synthesis of 2-chloro-1H-benzimidazole (3)
A mixture of 1,3-dihydro-benzimidazol-2-one (2) (10 g, 0.07 mol), phosphoryl chloride (22.88 g, 0.14 mol) and catalytic amount of phenol was heated 103-107 °C for 12 h. After completion of the reaction, the mixture was cooled and sodium hydroxide (40%, 25 mL) solution was added. The reaction mixture was stirred until it solidify. The crude material was recrystallized to obtain pure product 3 (2-chloro-1H-benzimidazole) (Scheme 1). Yield: 11 g, 97 %. M.p.: 208-209 °C (Lit. [22] : 207-211 °C).
General procedure for the synthesis of N-alkylated derivatives of 2-chloro-1H-benzimidazole (5a-e)
To a solution of 2-chloro-1H-benzimidazole (3) (13.10 mmol) and potassium carbonate (19.65 mmol) in water (10 mL) was added compound 4a-e (15.75 mmol) at room temperature. The reaction mixture was then heated to 70-75 °C for 3-4 h by TLC monitoring. After completion of reaction, added 20 mL ethyl acetate, stirred for 15 min layers were separated. Ethyl acetate layer was washed with 20 mL water, dried over sodium sulfate. After concentration of solvent under vacuum and recrystalization with aq. ethanol yielded corresponding N-substituted derivative (5a-e) as a white solid (Scheme 2) [23] .
General procedure for the synthesis of N-alkylated derivatives of 2-chloro-1H-benzimidazole (5f-j)
To a solution of 2-chloro-1H-benzimidazole (3) (13.10 mmol) and potassium carbonate (19.65 mmol) in acetone (12 mL) was added compound 4f-j (15.75 mmol) at room temperature. The reaction mixture was then heated to 50-55 °C for 4-6 h by TLC monitoring. After completion of reaction, solvent was evaporated and added 20 mL water and 25 mL ethyl acetate, stirred for 15 min layers were separated. Ethyl acetate layer was washed with 20 mL water, dried over sodium sulfate. After concentration of solvent under vacuum and recrystalization with aq. ethanol yielded corresponding Nsubstituted derivative (5f-j) as a white solid. (Scheme 3) [23] .
General procedure for the synthesis of N-alkylated derivatives of 2-chloro-1H-benzimidazole (5k-n)
To a solution of 2-chloro-1H-benzimidazole (3) 
Antimicrobial studies
Tested organisms
The newly synthesized compounds were screened for their antibacterial activity [24, 25] 
Antibacterial assay
The drugs found to be active in primary screening were similarly diluted to obtain 200, 125, 100, 62.5, 50, 25, and 12.5 μg/mL concentrations for secondary screening to test in a second set of dilution against all microorganisms. Inoculums size for test strain was adjusted to 1×10 6 CFU/mL (colony forming unit per milliliter) by comparing the turbidity (turbid metric method). Synthesized compounds were diluted to 2000 μg/mL concentration, as a stock solution. A control tube containing no antibiotic was immediately sub cultured (before inoculation) by spreading a loopful evenly over a quarter of plate of medium suitable for the growth of test organisms.
The tubes were then incubated at 37.8 °C for 24 h for bacteria. Ten μg/mL suspensions were further inoculated on appropriate media and growth was noted after 24 and 48 h. The lowest concentration, which showed no growth after spot subculture was considered as MIC for each drug. The highest dilution (lowest concentration) preventing appearance of turbidity was taken as MIC i.e., the amount of growth from the control tube before incubation (which represents the original inoculums) was compared. The test mixture should contain 1×10 6 CFU/mL organisms. 2% DMSO and sterilized distilled water was used as negative control, while ampicillin antibiotic (1 U strength) was used as positive control. A set of tubes containing only seeded broth and solvent controls were maintained under identical conditions so as to make sure that the solvent had no influence on strain growth. The result of this was significantly affected by the size of inoculums. The standard drug used in the present study was ampicillin for evaluating antibacterial activity which showed 100, 100, 250 and 100 μg/mL MIC against E. coli, P. aeruginosa, S. aureus, and S. pyogenes, respectively. For bacterial growth, in the present protocol, we have used Muller Hinton broth at 37.8 °C in aerobic condition for 24-48 h. Results of antimicrobial evaluation of derivatives 5a-n are shown in Table 1 . 5a  500  1000  >1000  5b  250  500  1000  5c  1000  500  500  5d  250  250  500  5e  500  250  >1000  5f  >1000  1000  >1000  5g  1000  500  500  5h  500  500  1000  5i  500  >1000  250  5j  1000  250  1000  5k  500  250  500  5l  >1000  500  500  5m 1000 1000 250 5n 500 >1000 1000 Nystatin 100 100 100 Griseofulvin 500 100 100
Antifungal assay
The same compounds were tested for antifungal activity as primary screening in six sets against Candida albicans, Aspergillus niger and Aspergillus clavatus at various concentrations of 1000, 500, 200 and 100 μg/mL as shown in Table 2 . Results were recorded in the form of primary and secondary screening. Synthesized compounds were diluted to 1000 μg/mL concentration, as a stock solution. The synthesized compounds which were found to be active in this primary screening were further tested in a second set of dilution against all microorganisms. Griseofulvin was used as a standard drug for antifungal activity, which showed 500, 100 and 100 μg/mL MIC against C. albicans, A. Niger and A. clavatus, respectively. 2% DMSO and sterilized distilled water was used as negative control, while Griseofulvin (1 U strength) was used as positive control. For fungal growth, in the present protocol, we have used Sabourauds dextrose broth at 28.8 °C in aerobic condition for 48 h. Results of antifungal evaluation of derivatives 5a-n are shown in Table 2 .
Results and discussion
We have synthesized a series of N-substituted 2-chloro-1H-benzimidazole derivatives using a known procedure and obtained products with good yield (5a-n). 1,3-Dihydro-benzimidazol-2-one (2) was synthesized from the reaction of ophenylenediamine with urea in dimethyl form amide (Scheme 1). Compound 2 was reacted with phosphoryl chloride in absent solvent to give 2-chloro-1H-benzimidazole 3 (Scheme 1). Compound 3 was combined with 3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (4a) in presence of potassium carbonate in water to yield 3-[2-(2-chloro-benzimi dazole-1-yl)-ethyl]-2-methyl-pyrido[1, 2-a]pyrimidine-4-one (5a) (Scheme 2). Its IR spectra showed the appearance of carbonyl absorption band at 1730 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 339.1 (M+1). Compound 3 was combined with 3-(2-chloro ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one (4b) in presence of potassium carbonate in water to yield 3-[2-(2-chloro-benzimidazole-1-yl)-ethyl]-2-methyl-6, 7, 8, 9-tetrahydro-pyrido[1,2-a]pyrimidine-4-one (5b) (Scheme 2). Its IR spectra showed the appearance of carbonyl absorption band at 1722 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 343.2 (M+1). Compound 3 was combined with 4-chloro-2,2-diphenylbutane nitrile (4c) in presence of potassium carbonate in water to yield 4-(2-chlorobenzimidazole-1-yl)-2,2-diphenyl-butyro nitrile (5c). Its IR spectra showed the appearance of nitrile absorption band at 2329 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 372.2 (M+1). Compound 3 was combined with 4-chloro-1-(4-fluorophenyl) butan-1-one (4d) in presence of potassium carbonate in water to yield 4-(2-chloro-benzimidazole-1-yl)-1-(4-fluoro-phenyl) -butan-1-one (5d). Its IR spectra showed the appearance of carbonyl absorption band at 1701 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 317.2 (M+1). Compound 3 was combined with 2-(chloromethyl)-4-methoxy pyridin-3-ol (4e) in presence of potassium carbonate in water to yield 2-chloro-1-(3,4-dimethoxy-pyridine-2-ylmethyl)-1H-benzimidazole (5e). Its IR spectra showed the appearance of methoxy absorption weak band at 2696 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 304.2 (M+1).
The reaction of compound 3 with phenylchloroformate (4f) in presence of potassium carbonate in acetone to yield 2-chloro-benzimidazole-1-carboxylic acid phenyl ester (5f) (Scheme 3). Its IR spectra showed the appearance of carbonyl absorption band at 1752 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 273.2 (M+1). Compound 3 was reacted with 2-methylbenzoyl chloride (4g) in presence of potassium carbonate in acetone to yield (2-chloro-benzimidazole-1-yl)-o-tolyl-methanone (5g). Its IR spectra showed the appearance of carbonyl absorption band at 1722 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 271.2 (M+1). Compound 3 was reacted with 1-bromo-4-(bromomethyl)benzene (4h) in presence of potassium carbonate in acetone to yield 1-(4-bromo-benzyl)-2-Chloro-1H-benzimidazole (5h). Its IR spectra showed the appearance of C-Br absorption band at 1021 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 322.2 (M+1). Compound 3 was reacted with 4-nitrobenzoyl chloride (4i) in presence of potassium carbonate in acetone to yield (2-Chloro-benzimidazole-1-yl)-(4-nitro-phenyl)-methanone (5i). Its IR spectra showed the appearance of carbonyl absorption band at 1722 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 302.2 (M+1). Compound 3 was reacted with hexylchloro formate (4j) in presence of potassium carbonate in acetone to yield 2-chloro-benzimidazole-1-carboxylic acid hexyl ester (5j). Its IR spectra showed the appearance of carbonyl absorption band at 1752 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 281.2 (M+1).
The reaction of compound 3 with N-(2-chloroethyl)-Nisopropylpropan-2-amine (4k) in presence of potassium carbonate in DMF to yield [2-(2-chloro-benzimidazole-1-yl)-ethyl]-diisopropyl-amine (5k) (Scheme 4). Its IR spectra showed the appearance of C-N Stretch alkyl absorption band at 1136 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 280.2 (M+1). Compound 3 was reacted with 4-bromobutanenitrile (4l) in presence of potassium carbonate in DMF to yield 4-(2-chloro-benzimidazole-1yl)-butyronitrile (5l). Its IR spectra showed the appearance of nitrile absorption band at 2329 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 220.2 (M+1). Compound 3 was reacted with ethyl 5-bromopentanoate (4m) in presence of potassium carbonate in DMF to yield 5-(2-chloro-benzimidazole-1yl)-pentanoic acid ethyl ester (5m). Its IR spectra showed the appearance of carbonyl absorption band at 1752 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 281.2 (M+1). Compound 3 was reacted with methyl 2-chloroacetate (4n) in presence of potassium carbonate in DMF to yield (2-chloro-benzimidazole-1yl)-acetic acid methyl ester (5n). Its IR spectra showed the appearance of carbonyl absorption band at 1752 cm -1 . Its mass spectrum showed a peak corresponding to its molecular ion at m/z 225.2 (M+1).
All the compounds prepared herein were screened for their antimicrobial activities. The structures of all the synthesized compounds were characterized by spectroscopic data, and allowed these molecules for study of antibacterial and antifungal activities (Table 1 and 2).
Conclusion
Newly synthesized N-substituted 2-chloro-1H-benzimidazole derivatives were thoroughly characterized and some of them (5c, 5d, 5e, 5h, 5i and 5j) were found to possess high activity against Escherichia coli whereas compounds 5a-n were highly active against Staphylococcus aureus and compound 5a and 5d have also exerted very good activity against Streptococcus pyogenes employed for screening when compared to the standard ampicillin. The compounds 5b and 5d exhibited antifungal activity. However, antifungal activity of the other synthesized compounds was unsatisfactory.
